Related Experiment Video
Updated: Dec 20, 2025
Transmembrane Domain Oligomerization Propensity determined by ToxR Assay
Published on: May 26, 2011
Membrane affinity of individual toxic protein oligomers determined at the single-molecule level
Simli Dey1, Anirban Das1, Arpan Dey1
1Department of Chemical Sciences, Tata Institute of Fundamental Research, Homi Bhabha Road, Colaba, Mumbai 400005, India. maiti@tifr.res.in.
Abstract:
Oligomers are the key suspects in protein aggregation-linked diseases, such as Alzheimer's and Type II diabetes, and most likely exert their toxicity by interacting with lipid membranes. However, the "which oligomer" question remains an obstacle in understanding the disease mechanism, as the exact identity of the toxic oligomer(s) is not yet known. Oligomers exist as a mixture of species of different sizes (i.e. as different 'n-mers') in a physiological solution, making it difficult to determine the properties of individual species. Here we demonstrate a method based on single-molecule photo-bleaching (smPB) which can provide an answer to the "which oligomer" question, at least as far as membrane affinity is concerned. We calculate the ratio of the oligomer size distribution of human Islet Amyloid Polypeptide (IAPP) in the aqueous phase and that on a coexisting artificial lipid bilayer, and this measures the relative membrane affinity of individual oligomeric species. A problem with smPB measurements is that they can be very sensitive to pre-measurement bleaching. Here we correct for pre-bleaching using a covalently linked multimeric peptide as a bleaching standard. We find that the order of membrane affinity for IAPP n-mers is trimer > dimer > tetramer ≫ monomer. Our results agree well with the average membrane affinity values of oligomeric and monomeric solutions previously measured with Fluorescence Correlation Spectroscopy. The "which oligomer" question, in the context of membrane affinity, can therefore, be solved quantitatively for any membrane-active toxic protein aggregate.
Insights
Identifying toxic oligomers in protein aggregation diseases is crucial. This study uses single-molecule photo-bleaching to measure the membrane affinity of individual human Islet Amyloid Polypeptide (IAPP) oligomers, revealing trimers have the highest affinity.
Area of Science:
- Biochemistry
- Biophysics
- Molecular Biology
Background:
- Protein oligomers are implicated in diseases like Alzheimer's and Type II diabetes, likely through interactions with lipid membranes.
- Identifying the specific toxic oligomer species remains a significant challenge in understanding disease mechanisms.
- Oligomers exist as heterogeneous mixtures in solution, complicating the study of individual species' properties.
Purpose of the Study:
- To develop and validate a method for determining the relative membrane affinity of individual protein oligomer species.
- To address the "which oligomer" question regarding toxicity by quantifying membrane interactions.
- To establish a quantitative approach for assessing the membrane affinity of different oligomeric states of human Islet Amyloid Polypeptide (IAPP).
Main Methods:
- Utilized single-molecule photo-bleaching (smPB) to analyze the size distribution of IAPP oligomers in aqueous and membrane-bound phases.
- Quantified relative membrane affinity by calculating the ratio of oligomer size distributions.
- Implemented a correction for pre-measurement bleaching using a covalently linked multimeric peptide as a standard.
Main Results:
- Established a quantitative method to measure the membrane affinity of individual oligomeric species.
- Determined the order of membrane affinity for IAPP oligomers: trimer > dimer > tetramer ≫ monomer.
- Results showed good agreement with previously obtained average membrane affinity values.
Conclusions:
- Single-molecule photo-bleaching (smPB) can quantitatively determine the relative membrane affinity of individual protein oligomers.
- The method provides a solution to the "which oligomer" question for membrane-active toxic protein aggregates.
- Understanding individual oligomer-membrane interactions is key to elucidating disease mechanisms.
